Karen Prange

ATRC

Karen Prange serves as Director at AtriCure, Inc. (ATRC). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$266.7K

Net Position

Net Seller

$266.7K

Companies Traded

ATRC

Active Period

Jun 2023 – Mar 2025

2 total trades

Most Recent

Sell ATRC

Mar 5, 2025 · $232.5K

Karen Prange's Insider Trading at AtriCure, Inc. (ATRC)

Buys

0 · $0.00

Sells

2 · $266.7K

Total Shares Bought

Total Shares Sold

6,813

ATRC Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 5, 2025↗	Sell	6,100	$38.12	$232.5K	0
Jun 8, 2023↗	Sell	713	$47.89	$34.1K	0

Related Insiders

Vinayak Doraiswamy

officer: Chief Scientific Officer

ATRCSell · Mar 16, 2026

Justin J Noznesky

Chief Mktg & Strategy Officer

ATRCSell · Nov 26, 2025

WEHRWEIN SVEN

Director

ATRCSell · Nov 24, 2025

Maggie Yuen

Director

ATRCSell · Nov 21, 2025

GROVES REGINA E

Director

ATRCSell · Aug 6, 2025

Vinayak Doraiswamy

Chief Scientific Officer

ATRCSell · Aug 5, 2025

Explore More Insider Trading Data

ATRC Insider Trading Activity

View all insider trades at AtriCure, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity